Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol exploratory single-arm study for glymphatic dysfunction after aneurysmal subarachnoid hemorrhage
jRCTs061260059Recruiting
- Sponsor
- Japan Society for the Promotion of Science
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cilostazol in subarachnoid hemorrhage (SAH), sponsored by Japan Society for the Promotion of Science. Primary endpoints: ALPS index at Day 21 and Delta ALPS from Day 3 to Day 21. Started Oct 2026; status: recruiting.
02
Drugs
cilostazol
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on jRCTs061260059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061260059.